@article{cb60419a6783414688a9205994b5c017,
title = "Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis",
author = "Kohei Takata and Yu Kataoka and Jordan Andrews and Rishi Puri and Muhammad Hammadah and Bhanu Duggal and Kapadia, \{Samir R.\} and Tuzcu, \{E. Murat\} and Nissen, \{Steven E.\} and Nicholls, \{Stephen J.\}",
note = "Funding Information: Please note: Dr. Nissen has received research support to perform clinical trials through the Cleveland Clinic Coordinating Center for Clinical Research from Pfizer, AstraZeneca, Novartis, Roche, Daiichi-Sankyo, Takeda, Sanofi-Aventis, Resverlogix, and Eli Lilly; and is a consultant or advisor for many pharmaceutical companies but requires them to donate all honoraria or consulting fees directly to charity so that he receives neither income nor a tax deduction. Dr. Nicholls has received speaking honoraria from AstraZeneca, Pfizer, Merck Schering-Plough, and Takeda; has received consulting fees from AstraZeneca, Abbott, Atheronova, Esperion, Amgen, Novartis, Omthera, CSL Behring, Boehringer Ingelheim, Pfizer, Merck Schering-Plough, Takeda, Roche, NovoNordisk, LipoScience, and Anthera; and has received research support from the National Health and Medical Research Council of Australia, Amgen, Esperion, The Medicines Company, Sanofi-Regeneron, Anthera, AstraZeneca, Cerenis, Eli Lilly, InfraReDx, Roche, Resverlogix, Novartis, Amgen, and LipoScience. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2018",
month = nov,
doi = "10.1016/j.jcmg.2018.02.017",
language = "English (US)",
volume = "11",
pages = "1721--1723",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",
number = "11",
}